Australia markets open in 5 hours 50 minutes

Universe Pharmaceuticals INC (UPC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5601-0.0699 (-4.29%)
As of 11:36AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 6.09M
Enterprise value -6.93M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.19
Price/book (mrq)0.15
Enterprise value/revenue -0.21
Enterprise value/EBITDA 2.18

Trading information

Stock price history

Beta (5Y monthly) 1.82
52-week change 3-56.85%
S&P500 52-week change 324.16%
52-week high 35.8800
52-week low 30.7500
50-day moving average 31.8268
200-day moving average 31.9814

Share statistics

Avg vol (3-month) 396.96k
Avg vol (10-day) 3109.82k
Shares outstanding 53.65M
Implied shares outstanding 63.65M
Float 81.55M
% held by insiders 157.05%
% held by institutions 10.22%
Shares short (31 Jan 2024) 45.03k
Short ratio (31 Jan 2024) 40.04
Short % of float (31 Jan 2024) 40.32%
Short % of shares outstanding (31 Jan 2024) 40.14%
Shares short (prior month 29 Dec 2023) 49.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 328 July 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)30 Sept 2023


Profit margin -19.08%
Operating margin (ttm)-26.56%

Management effectiveness

Return on assets (ttm)-3.91%
Return on equity (ttm)-14.34%

Income statement

Revenue (ttm)32.31M
Revenue per share (ttm)8.91
Quarterly revenue growth (yoy)-13.20%
Gross profit (ttm)N/A
Net income avi to common (ttm)-6.16M
Diluted EPS (ttm)-1.7000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.5M
Total cash per share (mrq)5.11
Total debt (mrq)5.48M
Total debt/equity (mrq)13.87%
Current ratio (mrq)2.68
Book value per share (mrq)10.91

Cash flow statement

Operating cash flow (ttm)1.12M
Levered free cash flow (ttm)1.59M